Welcome to chemicalbook!
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook > Product Catalogue >API >Blood System Drugs >Anticoagulant and Antiplatelet Drugs >Cilostazol

Cilostazol

Cilostazol Structure
  • ₹7500 - ₹80646.25
  • Product name: Cilostazol
  • CAS: 73963-72-1
  • MF: C20H27N5O2
  • MW: 369.46
  • EINECS:689-122-9
  • MDL Number:MFCD00866780
  • Synonyms:6-[4-(1-CYCLOHEXYL-1H-TETRAZOL-5-YL)BUTOXY]-3,4-DIHYDRO-2(1H)-QUINOLINONE;6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1h)-quinolinone additional name: 6-[4-(1-cyclohexyl-5-tetrazolyl)butoxy]-1,2,3,4- tetrahydro-2-oxoquinolinone;OPC-13013, Pletal, 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone;6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one;CILOSTAZOL JP;6-[4-(1-CYCLOHEXYL-1H-TETRAZOL-5-YL)BUTOXY]-3,4-DIHYDRO-2(1H)-QUINOLINONE(CILOSTAZOL);OPC 13013, OPC 21, Pletaal, 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone;6-[4-(1-Cyclohexyl-1H-tetrazol-5-y1)butoxy]-3,4-dihydrcr2(1H)-quinolinone
5 prices
Selected condition:

Brand

  • TCI Chemicals (India)
  • Sigma-Aldrich(India)

Package

  • 10MG
  • 50MG
  • 1G
  • 5G
  • ManufacturerTCI Chemicals (India)
  • Product numberC2587
  • Product descriptionCilostazol
  • Packaging1G
  • Price₹7500
  • Updated2022-05-26
  • Buy
  • ManufacturerTCI Chemicals (India)
  • Product numberC2587
  • Product descriptionCilostazol
  • Packaging5G
  • Price₹8000
  • Updated2022-05-26
  • Buy
  • ManufacturerSigma-Aldrich(India)
  • Product numberPHR1503
  • Product descriptionCilostazol Pharmaceutical Secondary Standard; Certified Reference Material
  • Packaging1G
  • Price₹15025.1
  • Updated2022-06-14
  • Buy
  • ManufacturerSigma-Aldrich(India)
  • Product numberC0737
  • Product descriptionCilostazol ≥98% (HPLC), powder
  • Packaging10MG
  • Price₹20177.8
  • Updated2022-06-14
  • Buy
  • ManufacturerSigma-Aldrich(India)
  • Product numberC0737
  • Product descriptionCilostazol ≥98% (HPLC), powder
  • Packaging50MG
  • Price₹80646.25
  • Updated2022-06-14
  • Buy
Manufacturer Product number Product description Packaging Price Updated Buy
TCI Chemicals (India) C2587 Cilostazol 1G ₹7500 2022-05-26 Buy
TCI Chemicals (India) C2587 Cilostazol 5G ₹8000 2022-05-26 Buy
Sigma-Aldrich(India) PHR1503 Cilostazol Pharmaceutical Secondary Standard; Certified Reference Material 1G ₹15025.1 2022-06-14 Buy
Sigma-Aldrich(India) C0737 Cilostazol ≥98% (HPLC), powder 10MG ₹20177.8 2022-06-14 Buy
Sigma-Aldrich(India) C0737 Cilostazol ≥98% (HPLC), powder 50MG ₹80646.25 2022-06-14 Buy

Properties

Melting point :159-160°C
Boiling point :499.57°C (rough estimate)
Density :1.1832 (rough estimate)
refractive index :1.7600 (estimate)
storage temp. :Inert atmosphere,Room Temperature
solubility :DMSO: 18 mg/mL, soluble
form :solid
pka :14.22±0.20(Predicted)
color :off-white
λmax :257nm(MeOH)(lit.)
Merck :14,2277
Stability :Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 2 months
InChIKey :RRGUKTPIGVIEKM-UHFFFAOYSA-N

Safety Information

Symbol(GHS): GHS hazard pictograms
Signal word: Warning
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
Precautionary statements:
P201 Obtain special instructions before use.
P202 Do not handle until all safety precautions have been read and understood.
P280 Wear protective gloves/protective clothing/eye protection/face protection.
P308+P313 IF exposed or concerned: Get medical advice/attention.
P405 Store locked up.
P501 Dispose of contents/container to..…

Description

Cilostazol is a quinolinone derivative first developed as an anti-thrombotic agent, inhibiting ADP-dependent platelet aggregation. This is mediated by selective and specific inhibition of cyclic nucleotide phosphodiesterase 3 (IC50 = 200 nM). Because of its effects on platelets, cilostazol is useful in various conditions, including peripheral artery disease, stroke, and post-stent stenosis. It is metabolized to products which also affect platelet aggregation by cytochrome P450 (CYP) isoforms CYP3A4, CYP3A5, and CYP1B1.

Related product price